Sofosbuvir And Ns5a Inhibitors Without Ribavirin During 12 Weeks Are Efficient To Treat Hepatitis C Recurrence After Liver Transplantation Only In Genotype 1. Results From The Co23 Anrs Cupilt Study. Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux , Victor De Ledinghen , Sylvie Radenne , Nassim Kamar , Vincent Leroy , Vincent Di Martino , Louis D'Alteroche , Valerie Canva-Delcambre , Filomena Conti , Jerome Dumortier , Helene Montialoux , Pascal Lebray , Danielle Botta-Fridlund , Rodolphe Anty , Christophe Moreno , Christine Silvain , Camille Besch , Philippe Perre , Claire Francoz , Armand Abergel , Francois Habersetzer , Maryline Debette-Gratien , Alexandra Rohel , Alpha Diallo , Emilie Rossignol , Helene Danjou , Aurelie Veislinger , Jean-Charles Duclos-Vallee , Georges-Philippe Pageaux TRANSPLANT INTERNATIONAL（2016）
Key words
liver transplantation, hepatitis, ribavirin
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
